A detailed history of La Fleur & Godfrey LLC transactions in Abbott Laboratories stock. As of the latest transaction made, La Fleur & Godfrey LLC holds 47,785 shares of ABT stock, worth $4.97 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
47,785
Previous 40,462 18.1%
Holding current value
$4.97 Million
Previous $4.45 Million 21.96%
% of portfolio
0.81%
Previous 0.66%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$109.52 - $120.96 $802,014 - $885,790
7,323 Added 18.1%
47,785 $5.43 Million
Q4 2023

Jan 18, 2024

BUY
$90.19 - $110.4 $174,156 - $213,182
1,931 Added 5.01%
40,462 $4.45 Million
Q3 2023

Oct 18, 2023

SELL
$95.53 - $114.62 $118,839 - $142,587
-1,244 Reduced 3.13%
38,531 $3.73 Million
Q2 2023

Jul 20, 2023

BUY
$100.78 - $112.29 $89,593 - $99,825
889 Added 2.29%
39,775 $4.34 Million
Q1 2023

Apr 18, 2023

BUY
$96.86 - $114.01 $27,605 - $32,492
285 Added 0.74%
38,886 $3.94 Million
Q4 2022

Jan 12, 2023

BUY
$95.06 - $111.52 $23,860 - $27,991
251 Added 0.65%
38,601 $0
Q3 2022

Oct 17, 2022

SELL
$96.76 - $112.03 $231,353 - $267,863
-2,391 Reduced 5.87%
38,350 $3.71 Million
Q2 2022

Jul 26, 2022

BUY
$102.07 - $123.37 $45,217 - $54,652
443 Added 1.1%
40,741 $4.43 Million
Q1 2022

May 03, 2022

BUY
$114.02 - $139.04 $247,423 - $301,716
2,170 Added 5.69%
40,298 $4.77 Million
Q4 2021

Jan 26, 2022

SELL
$115.53 - $141.46 $167,518 - $205,117
-1,450 Reduced 3.66%
38,128 $5.37 Million
Q3 2021

Nov 01, 2021

BUY
$116.66 - $129.06 $874,950 - $967,950
7,500 Added 23.38%
39,578 $4.68 Million
Q2 2021

Jul 19, 2021

BUY
$105.79 - $124.53 $3.39 Million - $3.99 Million
32,078 New
32,078 $3.72 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track La Fleur & Godfrey LLC Portfolio

Follow La Fleur & Godfrey LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of La Fleur & Godfrey LLC, based on Form 13F filings with the SEC.

News

Stay updated on La Fleur & Godfrey LLC with notifications on news.